{
  "ticker": "RAD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02958876",
  "id": "02958876",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250616",
  "time": "1656",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250616/pdf/06ksr1tr8ckg8w.pdf",
  "summary": "### Summary of Substantial Holding Notice for Radiopharm Theranostics Ltd (RAD):\n\n**Substantial Holder:**  \n- **Regal Funds Management Pty Ltd** (and associates)  \n\n**Changes in Voting Power:**  \n- Previous voting power: **6.15%**  \n- Current voting power: **8.30%** (145,362,288 shares)  \n\n**Key Changes in Holdings (Ordinary Shares):**  \n- **Purchases (Material):**  \n  - 31/03/2025: +40,000,000 shares (AUD 1,080,000.00)  \n  - 09/12/2024: +15,000,000 shares (AUD 584,970.00)  \n- **Sales (Material):**  \n  - 12/12/2024: -27,272,400 shares (shunt transaction)  \n  - 24/01/2025: -12,500,000 shares (AUD 337,500.00)  \n  - 03/04/2025: -13,858,939 shares (AUD 321,527.38)  \n\n**Dilution Event:**  \n- 11/06/2025: Holding diluted due to issuance of **30,969,360 new shares**.  \n\n**ADS Holdings (1 ADS = 300 ordinary shares):**  \n- Current ADS holdings: **35,276 ADS** (10,582,800 ordinary shares equivalent).  \n\n**Material Takeaway:**  \n- Significant **net increase in ownership** (2.15% voting power) with large purchases offset by partial disposals.  \n- Monitor for continued accumulation or dilution impact post-share issuance.  \n\n*(Omitted: Non-material trades, boilerplate, and associate details.)*",
  "usage": {
    "prompt_tokens": 2485,
    "completion_tokens": 376,
    "total_tokens": 2861,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-16T07:43:26.930783"
}